<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Axonics Modulation Technologies, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Axonics Modulation Technologies, Inc.

    Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) is a medical technology company focused on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions. SNM therapy is primarily used to treat patients with overactive bladder (“OAB”), fecal incontinence (“FI”) and urinary retention (“UR”). Axonics currently has marketing approvals in Europe, Canada, and Australia for OAB, FI, and UR. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $400,000,000
    • SIC CODE
      3841
    • NIN CODE
      ####
    • LEADERSHIP
      Raymond W. Cohen
    • FOUNDED
      2012
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Cocrystal Pharma, Inc.

    Cocrystal Pharma, Inc.

    Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and d...

    Cocrystal Pharma, Inc. is a clinical stage biot...

    Filing Type:    PU
    Eyenovia, Inc.

    Eyenovia, Inc.

    Eyenovia is a late-stage ophthalmic biopharmaceutical company developing breakthro...

    Eyenovia is a late-stage ophthalmic biopharmace...

    Filing Type:    PU
    T2 Biosystems, Inc.

    T2 Biosystems, Inc.

    T2 Biosystems, a leader in the development and commercialization of innovative med...

    T2 Biosystems, a leader in the development and ...

    Filing Type:    PU
    Quidel Corporation

    Quidel Corporation

    Quidel Corporation (Nasdaq: QDEL) is a California-based leading manufacturer of di...

    Quidel Corporation (Nasdaq: QDEL) is a Californ...

    Filing Type:    PU
    ACS Global, Inc.

    ACS Global, Inc.

    ACS Global, Inc. engages in the collection, processing, and long-term storage of s...

    ACS Global, Inc. engages in the collection, pro...

    Amount Raised:    $3,200,000
    Fundraising Status:    VT
    Filing Type:    PU
    Castle Biosciences, Inc.

    Castle Biosciences, Inc.

    Castle Biosciences is a skin cancer diagnostics company focused on providing physi...

    Castle Biosciences is a skin cancer diagnostics...

    Filing Type:    PU
    Bionano Genomics, Inc.

    Bionano Genomics, Inc.

    Bionano is a life sciences instrumentation company in the genome analysis space. B...

    Bionano is a life sciences instrumentation comp...

    Filing Type:    PU
    Pulse Biosciences, Inc

    Pulse Biosciences, Inc

    Pulse Biosciences is a bioelectric medicine company pursuing commercial introducti...

    Pulse Biosciences is a bioelectric medicine com...

    Filing Type:    PU
    Avedro, Inc

    Avedro, Inc

    We are committed to advancing the treatment of eye conditions such as keratoconus ...

    We are committed to advancing the treatment of ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.